Articles From: Inogen Announces Closing of Initial Public Offering to Inovio Pharmaceuticals Responds to Market Activity


2014/2/20
GOLETA, Calif., Feb.
Sign-up for Inogen Announces Closing of Initial Public Offering investment picks
2014/2/13
GOLETA, Calif., Feb.
Sign-up for Inogen Announces Pricing of Initial Public Offering investment picks
2014/3/27
- Strong Q4 2013 Revenue Growth of 43% Year over Year - GOLETA, Calif., March 27, 2014 (GLOBE NEWSWIRE) -- Inogen, Inc. (Nasdaq:INGN) , a medical technology company offering innovative respiratory products for use in the home care setting, today reported financial results for the three and twelve months ended December 31, 2013.
Sign-up for Inogen Releases Fourth Quarter and Full Year 2013 Financial Results and Provides 2014 Outlook investment picks
2014/3/12
GOLETA, Calif., March 12, 2014 (GLOBE NEWSWIRE) -- Inogen, Inc. (Nasdaq:INGN) , a medical technology company offering innovative respiratory products for use in the home care setting, announced today that it will release its financial results for the fourth quarter of 2013 after the close of trading on Thursday, March 27, 2014.
Sign-up for Inogen to Release Fourth Quarter 2013 Financial Results and Host Conference Call on Thursday, March 27, 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1047461&ProfileId=051205&sourceType=1 RALEIGH, NC --
Sign-up for InoLife Technologies Provides Corporate Outlook and Technology Focus for 2013 investment picks
2014/3/19
Sign-up for Inova Agro's Funding Decision Confirmed investment picks
Inova Agro's Results Postponed until February 18th Canada NewsWire About Verde Potash Verde Potash , a Brazilian fertilizer development company, is focused on advancing the Cerrado Verde project located in the heart of Brazil's largest agriculture market.
Sign-up for Inova Agro's Results Postponed until February 18th investment picks
2013/9/9
LAS VEGAS, Sept.
Sign-up for Inova Completes $3.5 Million of Projects for Dallas, Fort Worth and Socorro School Districts investment picks
2013/8/22
LAS VEGAS, Aug.
Sign-up for Inova Completes $750,000 of Projects for Clint Independent School District investment picks
2014/1/7
CHARLOTTE, N.C., Jan.
Sign-up for Inova Health System Expands Partnership With Premier, Inc. investment picks
INOVA Introduces the Highly Anticipated AccuSeis™ SL11 Digital Sensor for Land Seismic Acquisition Canada NewsWire HOUSTON , Sept.
Sign-up for INOVA Introduces the Highly Anticipated AccuSeis™ SL11 Digital Sensor for Land Seismic Acquisition investment picks
2013/9/23
HOUSTON , Sept.
Sign-up for INOVA Introduces the Highly Anticipated AccuSeis™ SL11 Digital Sensor for Land Seismic Acquisition investment picks
2013/8/6
LAS VEGAS, Aug.
Sign-up for Inova Releases 10K and Receives PO's for $3.5 Million of Projects for Fort Worth School District investment picks
LAS VEGAS, Sept.
Sign-up for Inova Revenue Increased 90% to $7.6 Million for Quarter investment picks
Technology Innovation Joins Health Plan and Physician Initiatives through the Electronic Health Record Platform to Improve Quality, Outcomes and Financial Performance in the Clinical Environment BOWIE, Md.
Sign-up for Inovalon and NextGen Healthcare Partner to Connect Advanced Analytics With The Point Of Care investment picks
2014/4/10
Inovalon's HEDIS Advantage™ QSI®-XL Solution Offers Technical Solution that Utilizes Big Data Processing and Analytics, Significantly Reducing Data Integration and Cycle Times BOWIE, Md.
Sign-up for Inovalon Drives Quality and HEDIS® Analytics Improvements Through Big Data Processing investment picks
2014/3/7
inovia , the leading foreign filing platform provider and independent operating unit of RWS Group (LON:RWS), announced the release of an expansive redesign of its foreign filing platform, inovia.com .
Sign-up for inovia Launches Redesign of its Foreign Filing Platform investment picks
No vaccine exists for the MERS virus that has killed 42% of those infected BLUE BELL, Pa.
Sign-up for Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial investment picks
2014/2/27
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock investment picks
2014/2/26
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Announces Public Offering of Common Stock investment picks
2014/2/18
New VPs of R&D and Clinical Development add extensive pharmaceutical and biotech immunotherapy product development experience BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies investment picks
2014/3/4
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing investment picks
2014/4/1
Immunotherapy and Vaccine Leader Also Promotes Three Executives in Legal, Clinical and Investor Relations BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality investment picks
2014/2/11
2014 Marks A Transformative Year for the Leader in DNA Vaccines and Cancer Immunotherapies BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Invited To Ring the Opening Bell® at the New York Stock Exchange on February 12 investment picks
2014/3/26
Biotech Judged First-in-Class for Cervical Pre-Cancer Immunotherapy (VGX-3100), Which Reports Phase II Results Mid-year 2014 Also Awarded "Best Vaccine Licensing Deal" and "Best Early Stage Biotech" BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014 investment picks
2014/3/17
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results investment picks
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results investment picks
Inovio marks quarter with significant partnership with Roche BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results investment picks
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Responds to Market Activity investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Inogen Announces Closing of Initial Public Offering to Inovio Pharmaceuticals Responds to Market Activity
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity